There are more than 50 million in-patient operations performed annually in the U.S. requiring pain relief for up to 5 days; in 2010 outpatient operations surpassed this and continue to grow. Reference:National Health Statistic Reports No. 102, February 28, 2017
Many of the pain relief products available are narcotics, which can have severe side effects. The current opioid crisis requires non-narcotic options for acute pain relief.
A transdermal formulation with a non-narcotic drug mitigates the potential for abuse of a potent drug and provides sustained pain relief for 24 hours and can be applied daily for up to 5 days.
Surgical pain can be intense (joint replacement surgery, cancer surgery, etc.)
Drugs used to treat this pain include the opiates, Oxycontin®, and fentanyl. These drugs have recently been targeted for rampant abuse.
Elliptical Therapeutics’ product utilizes a potent non-narcotic drug ketorolac tromethamine that is often used via injection or iv drip during surgery, and a nasal formulation used post-surgery; the patch could seamlessly move the patient from the operating room to post operative pain relief.
Our transdermal formulation mitigates the potential for abuse of a potent drug and provides sustained relief for 24 hours; additional patches can be administered over several days.
An emerging company using off-patent drugs in improved formulations to treat pain.